close

Clinical Trials

1 193 194 195
Number of results: 3888

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2008-03-05 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 1 Advantagene (USA - MA) Cancer - Oncology
2007-12-27 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 2a Advantagene (USA - MA) Cancer - Oncology
0000-00-00 ETS2101 (dexanabinol) Cancer - Oncology
0000-00-00 JNJ-54257099/AL-704 chronic hepatitits C 1 Alios Biopharma, a J&J company (USA - NJ) Janssen Pharmaceutica, a J&J company (USA - NJ) Infectious diseases
0000-00-00 PRX-102 (alpha-galactosidase-A) Fabry disease 3 Protalix BioTherapeutics (Israel) Rare diseases - Genetic diseases
0000-00-00 brilacidin-OM 2 Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA)
0000-00-00 brilacidin ulcerative proctitis/ulcerative proctosigmoiditis 2 Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA) Inflammatory diseases
0000-00-00 psoriasis Merck&Co (USA - NJ) Sun Pharmaceutical Industries (India) Autoimmune diseases - Dermatological diseases - Inflammatory diseases